Randomized Trialhigh evidence
Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial.
Stroke·July 6, 2026·PMID 42403344
Why it mattersThis trial provides evidence that a simple, low-cost intervention (NBO) may enhance EVT outcomes in late-window stroke patients, potentially expanding the therapeutic window for neuroprotection. It addresses a gap in adjunctive therapies for patients presenting beyond 6 hours, where treatment options are limited.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled